Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.
about
Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor CellsStudies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes.Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells.Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models.Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Ruthenium bistridentate complexes with non-symmetrical hexahydro-pyrimidopyrimidine ligands: a structural and theoretical investigation of their optical and electrochemical properties.Half-sandwich iridium N-heterocyclic carbene anticancer complexes.Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening.DNA Interaction, Photocleavage and Topoisomerase I Inhibition by Ru(II) Complex with a New Ligand Possessing Phenazine Unit.Ruthenium(II) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase.DNA interaction and photocleavage properties of Ru (II) complexes [Ru(bpy)₂(pibi)]²⁺ and [Ru(phen)₂(pibi)]²⁺.Novel ruthenium(II) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors.
P2860
Q36499563-55ABCF29-A11A-4D18-B209-118008CE4E33Q38735217-8D003266-98ED-4DC1-B74C-177EA988599DQ38838150-0DC05D01-F08D-4C58-93AE-47909D342122Q38941173-006C2564-3B1F-496B-BBE9-16758B121EE9Q38969205-4BF1E8E9-13D9-443B-9D36-702C651224F0Q39052398-74862CA7-500C-4813-AEBA-4B98A97A8B55Q39103148-E3395A52-FDFE-4C2B-BD55-23F0DAC9E1B0Q39153973-FE3C88B8-829A-4AC2-8FE5-E40CC881D39AQ39182036-045CA26C-41FF-48A5-BD68-A51FF26A2AE0Q39400527-9740BF31-3CAB-4262-BDB6-53B57BE14DF0Q39582838-C7732465-09E2-45AE-BA17-E399EA7B3EB7Q46384231-C7EF29F3-F8BA-47CD-A9A0-D1B565C7E99AQ50063144-B2D4C4C8-77BB-4636-807F-25A864B6F14BQ50798904-9154638A-F792-4368-B512-7E5CB71AD8DBQ51803957-7266F0AA-D49A-444B-839C-EF38AC84054FQ52974209-CA131AED-E899-43B0-BC42-7F2D5DA94F43Q53505708-C272874B-FD8B-4794-838C-3AF7F14C29A3Q53582568-04508845-337E-4BA1-83C3-B884C1065123
P2860
Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Chiral ruthenium
@nl
Chiral ruthenium(II) anthraqui ...... rs of topoisomerases I and II.
@en
type
label
Chiral ruthenium
@nl
Chiral ruthenium(II) anthraqui ...... rs of topoisomerases I and II.
@en
prefLabel
Chiral ruthenium
@nl
Chiral ruthenium(II) anthraqui ...... rs of topoisomerases I and II.
@en
P2093
P2860
P1476
Chiral ruthenium(II) anthraqui ...... rs of topoisomerases I and II.
@en
P2093
Jin-Quan Wang
Jun-Feng Kou
Li-Li Wang
Liang-Nian Ji
Xiang Chen
P2860
P2888
P356
10.1007/S00775-011-0831-6
P577
2011-08-21T00:00:00Z